Indications
Edematous syndrome of various origins, including chronic heart failure, liver, lung and kidney diseases;
arterial hypertension.
$30.00
Active ingredient: | |
---|---|
Dosage form: | |
Indications for use: |
Edematous syndrome of various origins, including chronic heart failure, liver, lung and kidney diseases;
arterial hypertension.
Increased sensitivity tions to torasemid or to any component of the drug;
Allergy to sulfonamides (sulfa protivomigrenoznae money or drugs culpability);
renal failure with anuria;
hepatic coma and precoma;
hypokalemia refractory;
refractory hyponatremia;
hypovolemia (hypotension with or without bore) or dehydration;
pronounced violations of the outflow of urine of any etiology (including unilateral lesion of the urinary tract);
glikozida intoxication:
acute glomerulonephritis;
sinoatrial and atrioventricular block II-1II degree;
decompensated aortic and mi Central stenosis;
hypertrophic obstructive cardiomyopathy;
increase in Central venous pressure (over 10 mm Hg. calendar);
arrhythmia;
chronic renal failure with increasing azotemia;
hyperuricemia;
the age of 18 years (safety and efficacy have not been established);
pregnancy;
breastfeeding;
concurrent use of aminoglycosides and cefalosporinas;
lactose intolerance, lactase deficiency or glucose-galactose unit of malabsorption.
Composition
active substance:
torasamide – 5.00 mg;
excipients:
lactose monohydrate-75.00 mg;
corn starch-17.50 mg;
sodium carboxymethyl starch (sodium starch glycolate, type A) – 1.00 mg;
colloidal silicon dioxide-0.75 mg;
magnesium stearate-0.75 mg.
Composition
Active ingredient:
torasamide – 5.00 mg;
excipients:
lactose monohydrate-75.00 mg;
corn starch-17.50 mg;
sodium carboxymethyl starch (sodium starch glycolate, type A) – 1.00 mg;
colloidal silicon dioxide-0.75 mg;
magnesium stearate-0.75 mg
A diuretic.
Edematous syndrome of various origins, including chronic heart failure, liver, lung and kidney diseases; arterial hypertension.
Hypersensitivity to torasemide or to any of the components of the drug;allergy to sulfonamides (sulfonamide antimicrobials or sulfopylmocsvips);renal failure with anuria;hepatic coma and precoma;refractory hypokalismia;refractory hyponatremia;hypovolemia (with or without arterial hypotension) or dehydration;severe urinary outflow disorders of any etiology (including unilateral urinary tract infection);glycoside intoxication: acute glomerulonephritis;sinoatrial and atrioventricular block II-1II degrees;decompensated aortic and mitral stenosis;hypertrophic obstructive cardiomyopathy;increased central venous pressure (over 10 mm Hg);arrhythmia;chronic renal failure with increasing azotemia;hyperurixmia;age up to 18 years (safety and efficacy have not been established);pregnancy;breast-feeding period;concomitant use of aminoglycosides and csfalosnorins;lactose intolerance, lactase deficiency, or glucose-galactose malabsorption.
From the sensory organs – visual impairment, hearing impairment, tinnitus and hearing loss (usually reversible), usually in patients with renal insufficiency or hypoprotxinsmis (nephrotic syndrome). From the cardiovascular system infrequently-oxysystole, arrhythmia, tachycardia. From the respiratory system – nosebleed. From the digestive system: – diarrhea; abdominal pain, flatulence, polydipsia; dry mouth, nausea, vomiting, loss of appetite, pancreatitis, dyspeptic disorders, intrahepatic cholestasis. Skin pruritus, rash, urticaria, erythema multiforme, exfoliative dermatitis, purpura, vasculitis, photosensitization – from the foot and foot tissues. Musculoskeletal disorders-frequency unknown-muscle weakness. On the part of the urinary system-increased frequency of urination, noliuria, nocturia; infrequently-frequent urge to urinate; oliguria, urinary retention (in patients with urinary tract obstruction), interstitial nephritis, hematuria. On the part of the reproductive system-decreased potency. From the side of metabolism-hypokalismia. hyponatremia, hypomagnesemia, hypocalcemia, hypochloremia, metabolic alkalosis, hypovolemia, dehydration (more often in elderly patients).
Inside, once a day, without chewing, with a sufficient amount of water.
Tablets can be taken at any convenient constant time, regardless of food intake. The usual starting dose is 10-20 mg once a day.
If necessary, the dose can be doubled until the desired effect is achieved.
Symptoms
Increased diuresis, accompanied by a decrease in the volume of circulating blood and a violation of the water-electrolyte balance of the blood, followed by a pronounced decrease in blood pressure, drowsiness and confusion, collapse. Gastrointestinal disorders may occur.
Treatment
There is no specific antidote. Provocation of vomiting, gastric lavage, activated charcoal. Treatment is symptomatic, reducing the dose or discontinuing the drug and simultaneously replenishing the volume of circulating blood and correcting the indicators of water-electrolyte balance and acid-base state under the control of the content of electrolytes in blood plasma and the level of hematocrit. Hemodialysis is ineffective because the elimination of torasemide and its metabolites is not accelerated.
Round flat-cylindrical tablets of white or almost white color with a chamfer and risk.
 In a dark place, at a temperature not exceeding 25 °C.
2 years
Torasemide
By prescription
Tablets
For adults as directed by your doctor
Heart Failure, Hypertension, Liver Damage
Reviews
There are no reviews yet